What does the Enniatins (B, B1) and Beauvericin, Urine test measure?

Why is Enniatins (B, B1) and Beauvericin, Urine measured?

Enniatins and beauvericin are emerging dietary mycotoxin exposures primarily from contaminated cereal grains and grain-based processed foods. Their clinical significance in human health at levels typically encountered in Western dietary exposure is not yet established by mainstream toxicological evidence — regulatory agencies have not set maximum residue limits or tolerable daily intakes for these compounds in most jurisdictions. In functional medicine mycotoxin panels, their detection reflects recent grain-based dietary exposure. The interpretive framework is evolving, and practitioners should communicate appropriate scientific uncertainty when discussing these analytes with patients. # REVIEWER FLAG: Enniatins and beauvericin have a limited clinical evidence base for health effects at dietary exposure levels — reviewer to assess whether interpretive claims require additional caveating for this platform.

Reference ranges

Standard reference

# REVIEWER FLAG: Confirm whether enniatins and beauvericin are included in the current MycoTOX panel — these emerging Fusarium mycotoxins have been added to expanded mycotoxin panels relatively recently. Confirm individual analyte reporting and reference ranges.

Functional medicine optimal

# REVIEWER FLAG: Confirm Mosaic Diagnostics' interpretive framework for enniatins and beauvericin — emerging mycotoxins with limited standardised clinical thresholds.

Units

ppb (µg/L), ng/g creatinine

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.